Promega
Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug
Promega will develop its microsatellite instability assay as a companion diagnostic for Incyte's anti-PD-1 drug candidate retifanlimab in endometrial cancer.
Automation Helps COVID-19 Testing Scale Up, but Supply Chain Disruptions Persist
High-throughput sample prep is becoming critical to COVID-19 testing scale-up, but some labs are experiencing shortages at this stage in the testing workflow.
Promega Maintains Microsatellite Instability IVD Plans Amid Evolving Cancer Test Landscape
The company expects to garner clearance for its platform in the US first for Lynch syndrome as it builds additional evidence for an immunotherapy application.
Promega Nabs CE Mark for Microsatellite Instability IVD
Promega will seek to expand use of the assay in Europe while it works through regulatory review of the test for companion diagnostic use in the US and Asia.
Co-Diagnostics, Promega Ink Manufacturing Deal for Coronavirus Test
Co-Diagnostics' test, which recently received Emergency Use Authorization in the US, is designed to detect the RdRp gene of the SARS-CoV-2 virus.